Japanese Pediatricians Want 1 Million Children Atop H1N1 Vaccine List
This article was originally published in PharmAsia News
A Japanese physicians group urged the government to give about 1 million children priority for receiving the H1N1 flu vaccine when it becomes available. The Japan Pediatric Society said the million children are considered high-risk with cancer, kidney failure or asthma or serious physical or mental disabilities. The society said the priority list should include another 5.5 million preschool children and parents of infants under a year old. The pediatricians also urged the government to provide those shots for free instead of charging recipients for each inoculation, as planned. (Click here for more
You may also be interested in...
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.
The US FDA has proposed moving two categories of hepatitis C diagnostics to class II from class III because they pose relatively low risk.